Serum lipoprotein(a) concentration and Apo(a) isoform under the condition of renal dysfunction

Miho Kuboyama1, Masato Ageta, Tabito Ishihara

  • 1Department of Internal Medicine, Miyazaki Prefectural Nichinan Hospital, Miyazaki, Japan. miho-k@miyazaki-catv.ne.jp

Insights

Chronic renal failure (CRF) patients exhibit elevated serum lipoprotein(a) (Lp(a)) levels, particularly those with high molecular weight apoprotein(a) (apo(a)) isoforms. Increased creatinine levels correlate with higher Lp(a) and HMW-apo(a) concentrations in CRF.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Clinical Chemistry

Background:

  • Serum lipoprotein(a) (Lp(a)) is a recognized independent risk factor for cardiac events.
  • Patients with chronic renal failure (CRF) commonly present with elevated serum Lp(a) concentrations.

Purpose of the Study:

  • To investigate the association between serum Lp(a) levels and apoprotein(a) (apo(a)) isoforms in patients with renal dysfunction.
  • To explore the relationship between Lp(a), apo(a) isoforms, and creatinine levels in a cohort with cardiovascular risk factors.

Main Methods:

  • Study included 130 patients with hypertension, hyperlipidemia, diabetes mellitus, and/or CRF.
  • Patients were stratified into two groups based on serum creatinine levels (CRF: Cr > 2.0 mg/dl; Controls: Cr < 1.2 mg/dl).
  • Serum Lp(a) concentration and apo(a) isoforms were analyzed in relation to renal function.

Main Results:

  • CRF patients demonstrated significantly higher serum Lp(a) concentrations compared to controls.
  • A high prevalence of high molecular weight (HMW)-apo(a) isoforms was observed in CRF patients.
  • Serum creatinine levels positively correlated with both HMW-apo(a) presence and serum Lp(a) concentration.

Conclusions:

  • Elevated serum Lp(a) in CRF is linked to specific apo(a) isoforms, particularly HMW variants.
  • Renal dysfunction, indicated by increased creatinine, is associated with higher Lp(a) and HMW-apo(a) levels.
  • These findings highlight the interplay between renal function, Lp(a), and cardiovascular risk in CRF patients.

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...